Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zydus Pharmaceuticals (USA) Inc. is the North American division of Zydus Lifesciences Limited, a leading global pharmaceutical company headquartered in India. The company specializes in the development, manufacturing, and marketing of a diverse portfolio of generic oral solids, liquids, and topical medications. Zydus has established a significant presence in the U.S. market, consistently ranking among the top generic companies by volume and maintaining a robust pipeline of Abbreviated New Drug Applications (ANDAs). Beyond generics, the company is increasingly focused on specialty pharmaceuticals and biosimilars, leveraging the extensive R&D capabilities of its parent organization. Their U.S. operations are supported by state-of-the-art manufacturing facilities and a commitment to providing affordable, high-quality healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zydus Pharmaceuticals USA.